Overview
Edward Chang is a Hematologist Oncology specialist and a Hematologist in Portland, Oregon. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Iron Deficiency Anemia, and Paget Disease of the Breast. Dr. Chang is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- PPO
- EPO
- PPO
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
265 N Broadway, Portland, OR 97227
5050 Ne Hoyt St, Suite 256, Portland, OR 97213
210 Se 136th Ave, Vancouver, WA 98684
12123 Sw 69th Ave, Tigard, OR 97223
Rachel Sanborn is an Oncologist in Portland, Oregon. Dr. Sanborn is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Bone Marrow Aspiration. Dr. Sanborn is currently accepting new patients.
University Professional Services
Annie Hung is a Hematologist Oncology specialist and an Oncologist in Portland, Oregon. Dr. Hung is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, Chronic B-Cell Leukemia (CBCL), and ALK-Positive Non-Small Cell Lung Cancer. Dr. Hung is currently accepting new patients.
University Professional Services
Jeremy Cetnar is an Oncologist and a Hematologist in Portland, Oregon. Dr. Cetnar is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Cetnar is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AgranulocytosisDr. Chang isAdvanced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Chang isAdvanced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Chang isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency Anemia
- Chronic B-Cell Leukemia (CBCL)Dr. Chang isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Familial NeutropeniaDr. Chang isAdvanced. Learn about Chronic Familial Neutropenia.
- Experienced
- Acquired AgranulocytosisDr. Chang isExperienced. Learn about Acquired Agranulocytosis.
- Acute Febrile Neutrophilic DermatosisDr. Chang isExperienced. Learn about Acute Febrile Neutrophilic Dermatosis.
- Acute Mountain SicknessDr. Chang isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Chang isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Chang isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer